In particular, CML-derived Exo promoted the proliferation and survival of CML cells, both in vitro and in vivo, by TGF-β1/TGF-β1 receptor engagement [77]. This evidence concerns the gene TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive.